Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2007Transactions of the Royal Society of Tropical Medicine and Hygiene

Sulfadoxine–pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKate KolaczinskiGlobal Fund to Fight AIDS, Tuberculosis and MalariaNDNaeem DurraniMerlin Circuit Technology (United Kingdom)SRSayed Rahim

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kolaczinski et al. (2007) studied this question.

synapsesocial.com/papers/6aacc69f493a6464efc0d668https://doi.org/10.1016/j.trstmh.2007.06.015
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan1999 · 52 citations
  2. 2CHLOROQUINE-RESISTANT PLASMODIUM VIVAX MALARIA IN PERU2003 · 125 citations
  3. 3Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan2001 · 40 citations
  4. 4Clinical trials of artemisinin and its derivatives in the treatment of malaria in China1994 · 150 citations
  5. 5Permethrin-treated chaddars and top-sheets: appropriate technology for protection against malaria in Afghanistan and other complex emergencies1999 · 121 citations